Featured Research

from universities, journals, and other organizations

Benefits From Upper Airway Surgery For Sleep Apnea Found To Equal CPAP

Date:
August 20, 2009
Source:
American Academy of Otolaryngology -- Head and Neck Surgery
Summary:
Adults who struggle with CPAP treatment for obstructive sleep apnea should be considered candidates for reconstructive surgery on the upper airway, because it holds the same quality-of-life benefits but with more permanence.

Adults who struggle with CPAP treatment for obstructive sleep apnea (OSA) should be considered candidates for reconstructive surgery on the upper airway, because it holds the same quality-of-life (QOL) benefits but with more permanence.

Continuous positive airway pressure (CPAP) therapy is a highly effective means for treating obstructive sleep apnea, but because it involves a mask and set of hoses, it can be frustrating and uncomfortable for some patients, and compliance may be short-lived.

The Australian authors of the study discovered that among moderate-to-severe OSA-suffering patients, those treated through upper airway surgery experienced the same level of long-term quality-of-life improvement as their peers who were treated with CPAP therapy. Among the QOL benefits were improvements in snoring, sleepiness, and neurocognitive impairment. In contrast, those patients who were prescribed, but did not adequately use CPAP, had minimal QOL improvement.

The upper airway includes nose and throat (pharyngeal) areas, particularly behind the soft palate and tongue. Reconstructive surgery to treat sleep apnea involves clearing any blockages in those areas that might be hindering breathing.

This thesis is in new research published in the August 2009 edition of Otolaryngology-Head and Neck Surgery. The study's authors are Sam Robinson, MB, BS, FRACS; Michael Chia, MB, BS, FRACP; A. Simon Carney, MB, ChB, MD, FRCS, FRACS; Sharad Chawla, MB, BS, MS (ENT); Penelope Harris, BSc (Hons); and Adrian Esterman, PhD, MSc, BSc (hons), DLSHTM.


Story Source:

The above story is based on materials provided by American Academy of Otolaryngology -- Head and Neck Surgery. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Otolaryngology -- Head and Neck Surgery. "Benefits From Upper Airway Surgery For Sleep Apnea Found To Equal CPAP." ScienceDaily. ScienceDaily, 20 August 2009. <www.sciencedaily.com/releases/2009/08/090801092708.htm>.
American Academy of Otolaryngology -- Head and Neck Surgery. (2009, August 20). Benefits From Upper Airway Surgery For Sleep Apnea Found To Equal CPAP. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/08/090801092708.htm
American Academy of Otolaryngology -- Head and Neck Surgery. "Benefits From Upper Airway Surgery For Sleep Apnea Found To Equal CPAP." ScienceDaily. www.sciencedaily.com/releases/2009/08/090801092708.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins